pU6-Cj-sgRNA Citations (3)
Originally described in: In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni.Kim E, Koo T, Park SW, Kim D, Kim K, Cho HY, Song DW, Lee KJ, Jung MH, Kim S, Kim JH, Kim JH, Kim JS Nat Commun. 2017 Feb 21;8:14500. doi: 10.1038/ncomms14500. PubMed Journal
Articles Citing pU6-Cj-sgRNA
| Articles |
|---|
MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression in vivo.
Zhang X, Lv S, Luo Z, Hu Y, Peng X, Lv J, Zhao S, Feng J, Huang G, Wan QL, Liu J, Huang H, Luan B, Wang D, Zhao X, Lin Y, Zhou Q, Zhang ZN, Rong Z.
Nucleic Acids Res. 2021 Mar 22. pii: 6179929. doi: 10.1093/nar/gkab174.
PubMed
Associated Plasmids |
| Adenine base editing of the DUX4 polyadenylation signal for targeted genetic therapy in facioscapulohumeral muscular dystrophy. Sikrova D, Cadar VA, Ariyurek Y, Laros JFJ, Balog J, van der Maarel SM. Mol Ther Nucleic Acids. 2021 Jun 1;25:342-354. doi: 10.1016/j.omtn.2021.05.020. eCollection 2021 Sep 3. PubMed |
| Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery. Kweon J, Jang AH, Kwon E, Kim U, Shin HR, See J, Jang G, Lee C, Koo T, Kim S, Kim Y. Exp Mol Med. 2023 Feb;55(2):377-384. doi: 10.1038/s12276-023-00938-w. Epub 2023 Feb 1. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.